Alnylam, Nastech Take Different IP Approaches To Pandemic Flu RNAi Therapies
Alnylam predicts companies will come knocking on its door to license its intellectual property in the field.
Alnylam predicts companies will come knocking on its door to license its intellectual property in the field.